Bone/calvaria Antibody
Bone/calvaria Antibody
Rat Bone, Calvaria Total Protein* |
|||
RT-108 | Zyagen | 0.5mg | 319 EUR |
Rat Bone, Calvaria Frozen Sections* |
|||
RF-108 | Zyagen | 10 slides | 393 EUR |
Rat WS Bone, Calvaria Total RNA |
|||
RR-108-WS | Zyagen | 0.025mg | 341 EUR |
Rat Bone, Calvaria Paraffin Sections* |
|||
RP-108 | Zyagen | 10 slides | 393 EUR |
Mouse CD1 Bone, Calvaria Total RNA |
|||
MR-108 | Zyagen | 0.025mg | 341 EUR |
Mouse C57 Bone, Calvaria Total RNA |
|||
MR-108-C57 | Zyagen | 0.025mg | 368 EUR |
Rat WS Bone, Calvaria Total Protein* |
|||
RT-108-WS | Zyagen | 0.5mg | 319 EUR |
Mouse CD1 Bone, Calvaria Tissue cDNA* |
|||
MD-108 | Zyagen | 30 reactions | 395 EUR |
Mouse BLC Bone, Calvaria Tissue cDNA* |
|||
MD-108-BLC | Zyagen | 30 reactions | 434 EUR |
Mouse C57 Bone, Calvaria Tissue cDNA* |
|||
MD-108-C57 | Zyagen | 30 reactions | 434 EUR |
Mouse Balbc Bone, Calvaria Total RNA |
|||
MR-108-BLC | Zyagen | 0.025mg | 334 EUR |
Rat WS Bone, Calvaria Frozen Sections* |
|||
RF-108-WS | Zyagen | 10 slides | 393 EUR |
Mouse CD1 Bone, Calvaria Total Protein* |
|||
MT-108 | Zyagen | 0.5mg | 319 EUR |
Mouse BLC Bone, Calvaria Total Protein* |
|||
MT-108-BLC | Zyagen | 0.5mg | 344 EUR |
Mouse C57 Bone, Calvaria Total Protein* |
|||
MT-108-C57 | Zyagen | 0.5mg | 344 EUR |
Rat WS Bone, Calvaria Paraffin Sections* |
|||
RP-108-WS | Zyagen | 10 slides | 393 EUR |
Rat Bone, Calvaria cDNA-Random Primer * |
|||
RD-108-RH | Zyagen | 30 reactions | 395 EUR |
Mouse CD1 Bone, Calvaria Frozen Sections* |
|||
MF-108 | Zyagen | 10 slides | 393 EUR |
Mouse BLC Bone, Calvaria Frozen Sections* |
|||
MF-108-BLC | Zyagen | 10 slides | 418 EUR |
Mouse C57 Bone, Calvaria Frozen Sections* |
|||
MF-108-C57 | Zyagen | 10 slides | 418 EUR |
Mouse CD1 Bone, Calvaria Paraffin Sections* |
|||
MP-108 | Zyagen | 10 slides | 393 EUR |
Mouse BLC Bone, Calvaria Paraffin Sections* |
|||
MP-108-BLC | Zyagen | 10 slides | 418 EUR |
Mouse C57 Bone, Calvaria Paraffin Sections* |
|||
MP-108-C57 | Zyagen | 10 slides | 418 EUR |
Rat WS Bone, Calvaria cDNA-Oligo-dT * |
|||
RD-108-WS | Zyagen | 30 reactions | 395 EUR |
Mouse C57 Bone, Calvaria Tissue cDNA-Random Primer* |
|||
MD-108-C57-RH | Zyagen | 30 reactions | 434 EUR |
Mouse CD1 Bone, Calvaria Tissue cDNA-Random Primer* |
|||
MD-108-HR | Zyagen | 30 reactions | 395 EUR |
Rat Calvariae Osteoblasts |
|||
ABC-TC4102 | AcceGen | 1 vial | Ask for price |
Description: Rat Calvariae Osteoblasts are dissociated from Sprague Dawley rat embryos. These cells offer an excellent model system for the study of osteoblastic growth and mineralization and can be used in research applications for bone disease, repair and formation. |
|||
Rat Calvarial Osteoblasts |
|||
ABC-TC4103 | AcceGen | 1 vial | Ask for price |
Description: Rat Calvarial Osteoblasts (RCO) are isolated from the calvaria bone of neonatal Sprague-Dawley rats. RCO are cryopreserved at primary cultures and delivered frozen. RCO are guaranteed to further expand for 10 population doublings in the conditions provided by Gentaur. |
|||
Rat Calvariae Osteoblasts |
|||
LOR-OST-583 | Westburg | each | 941.15 EUR |
Human Calvarial Osteoblast |
|||
ABC-TC3531 | AcceGen | 1 vial | Ask for price |
Description: Bone is a dynamic tissue, being continuously remodeled by the coordinated actions of osteoclasts and osteoblast lineage. Osteoblasts, the bone-forming cells, are derived originally from pluripotent mesenchymal stem cells. They synthesize and secrete organic extracellular matrix, osteoid, which is composed primarily of type I collagen. Osteoid is calcified by osteoblasts and during this process the cells become encased in lacunae within the calcified material and become osteocytes. Osteoblasts express protease-activated receptor-1 and vescular endothelial cell growth factor. Studies show that Leukemia inhibitory factor can bind to the osteoblast cell surface and induce bone formation both in vitro and in vivo. The balance between osteoblast recruitment, proliferation, differentiation and apoptosis in sutures between cranial bones is essential for calvarial bone formation.HCO from Gentaur Research Laboratories are isolated from human calvariae. HCO are cryopreserved at primary cultures and delivered frozen. Each vial contains 5×10^5 cells in 1 ml volume. HCO are characterized by the cytochemically detection of AP and mineral deposition. HCO are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HCO are guaranteed for 15 population doublings at the conditions provided by Gentaur Research Laboratories. |
|||
Immortalized Mouse Calvarial Mesenchymal Progenitor Cells (iCALs) |
|||
T0019 | ABM | 1x106 cells / 1.0 ml | 3950 EUR |
Bone Marrow antibody |
|||
10R-7946 | Fitzgerald | 100 ug | 586.8 EUR |
Description: Mouse monoclonal Bone Marrow antibody |
|||
Bone Marrow antibody |
|||
MBS834832-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Bone Sialoprotein Antibody |
|||
45125-100ul | SAB | 100ul | 302.4 EUR |
Bone Sialoprotein Antibody |
|||
45125-50ul | SAB | 50ul | 224.4 EUR |
Bone Sialoprotein Antibody |
|||
E19-7738-1 | EnoGene | 50ug/50ul | 145 EUR |
Description: Available in various conjugation types. |
|||
Bone Sialoprotein Antibody |
|||
E19-7738-2 | EnoGene | 100ug/100ul | 225 EUR |
Description: Available in various conjugation types. |
|||
Bone Sialoprotein Antibody |
|||
DF7738 | Affbiotech | 200ul | 420 EUR |
Bone Sialoprotein Antibody |
|||
DF7738-100ul | Affinity Biosciences | 100ul | 280 EUR |
Bone Sialoprotein Antibody |
|||
DF7738-200ul | Affinity Biosciences | 200ul | 350 EUR |
Bone Sialoprotein Antibody |
|||
MBS8517114-005mg | MyBiosource | 0.05mg | 235 EUR |
Bone Sialoprotein Antibody |
|||
MBS8517114-01mg | MyBiosource | 0.1mg | 305 EUR |
Bone Sialoprotein Antibody |
|||
MBS8517114-01mLAF405M | MyBiosource | 0.1mL(AF405M) | 465 EUR |
Bone Sialoprotein Antibody |
|||
MBS8517114-01mLAF546 | MyBiosource | 0.1mL(AF546) | 465 EUR |
Bone Sialoprotein Antibody |
|||
MBS8517114-01mLAF750 | MyBiosource | 0.1mL(AF750) | 465 EUR |
Bone Sialoprotein Antibody |
|||
MBS9608317-01mL | MyBiosource | 0.1mL | 260 EUR |
Bone Sialoprotein Antibody |
|||
MBS9608317-02mL | MyBiosource | 0.2mL | 305 EUR |
Bone Sialoprotein Antibody |
|||
MBS9608317-5x02mL | MyBiosource | 5x0.2mL | 1220 EUR |
Bone Sialoprotein Antibody |
|||
ABD7738 | Lifescience Market | 100 ug | 525.6 EUR |
Bone Sialoprotein (BSP) Antibody |
|||
20-abx171455 | Abbexa |
|
|
Bone Sialoprotein (BSP) Antibody |
|||
20-abx175605 | Abbexa |
|
|
Bone Sialoprotein (BSP) Antibody |
|||
20-abx175606 | Abbexa |
|
|
Bone Sialoprotein (BSP) Antibody |
|||
20-abx175607 | Abbexa |
|
|
Bone Sialoprotein (BSP) Antibody |
|||
abx171455-1ml | Abbexa | 1 ml | 750 EUR |
Bone Sialoprotein (BSP) Antibody |
|||
abx175605-1096tests | Abbexa | 10 × 96 tests | Ask for price |
Bone Sialoprotein (BSP) Antibody |
|||
abx175605-596tests | Abbexa | 5 × 96 tests | Ask for price |
Bone Sialoprotein (BSP) Antibody |
|||
abx175605-96tests | Abbexa | 96 tests | 712.5 EUR |
Bone Sialoprotein (BSP) Antibody |
|||
abx175606-1096tests | Abbexa | 10 × 96 tests | 725 EUR |
Bone Sialoprotein (BSP) Antibody |
|||
abx175606-596tests | Abbexa | 5 × 96 tests | 337.5 EUR |
Bone Sialoprotein (BSP) Antibody |
|||
abx175606-96tests | Abbexa | 96 tests | 262.5 EUR |
Bone Sialoprotein (IBSP) Antibody |
|||
20-abx216122 | Abbexa |
|
|
IBSP Antibody / Bone Sialoprotein2 |
|||
R30987 | NSJ Bioreagents | 100 ug | 356.15 EUR |
Description: Integrin-binding sialoprotein, also known as Bone sialoprotein and BSP, is a major structural protein of the bone matrix. Bone sialoprotein is a predicted 35KD acidic glycoprotein that undergoes extensive posttranslational modifications and is visualized by western blot at up to 70KD. It constitutes approximately 12% of the noncollagenous proteins in human bone and is synthesized by skeletal-associated cell types, including hypertrophic chondrocytes, osteoblasts, osteocytes, and osteoclasts. The only extraskeletal site of its synthesis is the trophoblast. This protein binds to calcium and hydroxyapatite via its acidic amino acid clusters, and mediates cell attachment through an RGD sequence that recognizes the vitronectin receptor. The BSP gene is mapped to 4q22.1. |
|||
Bone Alkaline Phosphatase Antibody |
|||
GWB-35D182 | GenWay Biotech | 0.1 mg | Ask for price |
Bone Sialoprotein Conjugated Antibody |
|||
C45125 | SAB | 100ul | 476.4 EUR |
Bone Sialoprotein Conjugated Antibody |
|||
MBS9453077-01mLAF350 | MyBiosource | 0.1mL(AF350) | 480 EUR |
Bone Sialoprotein Conjugated Antibody |
|||
MBS9453077-01mLAF405 | MyBiosource | 0.1mL(AF405) | 480 EUR |
Bone Sialoprotein Conjugated Antibody |
|||
MBS9453077-01mLAF488 | MyBiosource | 0.1mL(AF488) | 480 EUR |
Bone Sialoprotein Conjugated Antibody |
|||
MBS9453077-01mLAF555 | MyBiosource | 0.1mL(AF555) | 480 EUR |
Bone Sialoprotein Conjugated Antibody |
|||
MBS9453077-01mLBiotin | MyBiosource | 0.1mL(Biotin) | 480 EUR |
Bone Sialoprotein 2 (IBSP) Antibody |
|||
20-abx126940 | Abbexa |
|
|
Bone Sialoprotein 2 (IBSP) Antibody |
|||
abx027806-400ul | Abbexa | 400 ul | 627.6 EUR |
Bone Sialoprotein 2 (IBSP) Antibody |
|||
abx027806-80l | Abbexa | 80 µl | 343.2 EUR |